Please note: AABB reserves the right to make updates to this program.
Live Program: Wednesday, November 8, 2017 -
Master Program Number: 17EL-168 (see program format numbers below under Registration)
Educational Track: Technical/Clinical
Topic: Transfusion Medicine (Hemovigilance)
Intended Audience: Director, Donor Recruitment Staff, Managers/Supervisors, Medical Directors, Nurses, Physicians, Research Scientist, Students (MD, MT, SBB)
Teaching Level: Basic to Advanced
Director: Barbee Whitaker, PhD, Director, Research and Patient Safety, AABB, Bethesda, MD
Moderator: James Stubbs, MD, Medical Director, Mayo Clinic-Rochester, Rochester, MN
Speakers: Kevin Land, MD, Vice President, Clinical Services, Blood Systems, Inc., Fair Oaks, TX; Mary Townsend, MD, Senior Medical Director, Blood Systems, Inc., Scottsdale, AZ
After participating in this educational activity, participants should be able to:
- Categorize donor reactions using the AABB-ISBT harmonized definitions.
- Understand the critical differences between reaction categories.
- Recognize the value of internationally harmonized definitions.
This program will include an extensive review of donor adverse reaction cases that illustrate and distinguish the harmonized AABB-ISBT adverse reaction definitions. As the title indicates, the results of an extensive case study review will be utilized to demonstrate the signs and symptoms of donor reactions and the differences between reaction types and categories. The speakers will discuss the development process for the internationally harmonized definitions.
| || ||
|Single Viewer: On-Demand||
|Group Viewing: On-Demand||
Dr. Kevin Land serves as the Vice President of Clinical Services for Blood Systems - which includes oversight of Blood Systems Laboratory, therapeutic apheresis and cellular therapy services, and hospital-facing physicians. He is also the Chief Medical Officer for the Blood Services Division in North Dakota, South Dakota, Wyoming, and Montana. He is a Clinical Informaticist and patient-oriented Transfusion Medicine physician who has focused much of his career on systems design and process improvement to improve donor and patient safety. A Texas native, Dr. Land earned his bachelor’s degree in Biochemistry in 1990 from the University of North Texas and completed his medical degree and residency in Pathology at UT Southwestern in Dallas. After serving as chief resident, he completed fellowships in medical informatics at Johns Hopkins and transfusion medicine at Parkland Memorial Hospital.
Dr. Mary Townsend serves as the Senior Medical Director, Corporate at Blood Systems in Scottsdale. Prior to joining BSI in September 2010, she served as the Vice President of Coffee Memorial Blood Center in Amarillo Texas for 24 years, where she is on clinical faculty of the Department of Internal Medicine of Texas Tech University Medical School.
Born in Nocona Texas, Mary earned her bachelor’s degree in Chemistry and her master’s degree in Physical Chemistry prior to attending medical school at UT Southwestern in Dallas, TX. She trained in Obstetrics and Gynecology at the University of Pennsylvania and completed her residency in Clinical Pathology at the Medical College of Pennsylvania.
Mary has spent her career focusing on the care and feeding of donors, for whom she has an abiding passion. She was an inaugural member of the AABB Task Force to redesign the uniform donor questionnaire, serving as its second chair. She chaired both the America’s Blood Centers’ Scientific, Medical, Technical and Quality committee and the ABC Donor Adverse Event committee. She has been a member of the AABB Donor Biovigilance Working Group since its inception and was one of three centers to pilot the DonorHart Biovigilance system. She has been an editor of Notify Library since 2015, focusing on donor adverse events and infectious events in recipients.